Company profile

Aptar Pharma

aptar.comHeadquarters: United States
10001+ employeesHybrid (Product + Service)
Aptar Pharma logo

Primary focus

Drug delivery solutions, services, and technologies for pharmaceutical companies.

Why it’s included

The profile explicitly lists multiple inhaler and nasal-spray device products and components, such as the 'DF30 Metering Valve' and 'VP7 Spray Pump,' and details in-house development and manufacturing of these technologies for orally inhaled and intranasal drug products.

Relevant capabilities

  • Pulmonary and inhalation device development
  • Nasal delivery system design
  • Mesh and soft‑mist nebuliser engineering with guided‑breathing control
  • Metering valve and pMDI component engineering
  • Breath‑actuated delivery mechanisms
Commercial sectorInhalation Component and Excipient Suppliers
Technology classesPressurized metered dose inhaler (pMDI) mechanisms, Nasal spray delivery mechanisms, Digital integration in inhalation devices, Inhaled and nasal product testing and characterization

Relevant commercial products

  • DF30 Metering Valve
  • ZEN30 Futurity Metering Valve
  • VP3 Multi-dose Spray Pump
  • VP7 Spray Pump
  • CPS Technology Platform

← Back to what’s inside this report